CDIO
Cardio Diagnostics Holdings Inc
NASDAQ: CDIO · HEALTHCARE · BIOTECHNOLOGY
$1.70
-1.16% today
Updated 2026-04-29
Market cap
$5.39M
P/E ratio
—
P/S ratio
363.32x
EPS (TTM)
$-3.71
Dividend yield
—
52W range
$1 – $14
Volume
4.2M
Cardio Diagnostics Holdings Inc (CDIO) Financial statements
SEC filings — annual and quarterly data.
Income statement — annual
| Item | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|
| Revenue | $0.00 | $901.00 | $950.00 | $17065.00 | $34890.00 | $14825.00 |
| Revenue growth (YoY) | — | — | +5.4% | +1696.3% | +104.5% | -57.5% |
| Cost of revenue | — | — | $16000.00 | $111620.00 | $276345.00 | $398128.00 |
| Gross profit | — | $901.00 | $950.00 | $17065.00 | $34890.00 | $-383303.00 |
| Gross margin | — | 100.0% | 100.0% | 100.0% | 100.0% | -2585.5% |
| R&D | $1500.00 | $31468.00 | $40448.00 | $145182.00 | $29125.00 | $641212.00 |
| SG&A | $591521.00 | $470563.00 | $4.40M | $6.94M | $8.17M | $5.79M |
| Operating income | $-609164.00 | $-620448.00 | $-4.55M | $-7.24M | $-8.37M | $-6.48M |
| Operating margin | — | -68862.2% | -478784.3% | -42440.4% | -23977.9% | -43737.5% |
| EBITDA | $-598497.00 | $-604448.00 | $-4.64M | $-1.53M | $-8.09M | $-6.09M |
| EBITDA margin | — | -67086.3% | -488945.8% | -8966.9% | -23182.8% | -41051.9% |
| EBIT | $-609164.00 | $-620448.00 | $-4.66M | $-1.64M | $-8.36M | $-6.48M |
| Interest expense | — | — | $0.00 | $6.74M | $18640.00 | $14801.00 |
| Income tax | — | — | — | — | — | — |
| Effective tax rate | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% |
| Net income | $-605164.00 | $-620448.00 | $-4.66M | $-8.38M | $-8.38M | $-6.50M |
| Net income growth (YoY) | — | -2.5% | -651.2% | -79.7% | -0.1% | +22.5% |
| Profit margin | — | -68862.2% | -490630.0% | -49087.8% | -24028.2% | -43832.5% |